Correlation Between Ventyx Biosciences and Apellis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ventyx Biosciences and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Ventyx Biosciences and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Apellis Pharmaceuticals.

Diversification Opportunities for Ventyx Biosciences and Apellis Pharmaceuticals

0.95

Correlation Coefficient

Ventyx Biosciences  Apellis Pharmaceuticals

Almost no diversification

The 3 months correlation between Ventyx and Apellis is 0.95. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Apellis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ventyx Biosciences and Apellis Pharmaceuticals

Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Ventyx Biosciences is 1.41 times more volatile than Apellis Pharmaceuticals. It trades about -0.19 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.12 per unit of volatility. If you would invest  3,190  in Apellis Pharmaceuticals on December 29, 2024 and sell it today you would lose (762.00) from holding Apellis Pharmaceuticals or give up 23.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Ventyx Biosciences  vs.  Apellis Pharmaceuticals

Ventyx Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ventyx Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Apellis Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apellis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Ventyx Biosciences and Apellis Pharmaceuticals

The main advantage of trading using opposite Ventyx Biosciences and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.

The idea behind Ventyx Biosciences and Apellis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.